Adam J. Townsend - Net Worth and Insider Trading
Adam J. Townsend Net Worth
The estimated net worth of Adam J. Townsend is at least $3 Million dollars as of 2024-11-07. Adam J. Townsend is the Chief Commercial Officer of Apellis Pharmaceuticals Inc and owns about 92,453 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $3 Million. Details can be seen in Adam J. Townsend's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adam J. Townsend has not made any transactions after 2024-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adam J. Townsend
Adam J. Townsend Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adam J. Townsend owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Adam J. Townsend’s form 4 insider trades.
Insider Ownership Summary of Adam J. Townsend
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-02-12 | See Remarks |
Adam J. Townsend Latest Holdings Summary
Adam J. Townsend currently owns a total of 1 stock. Adam J. Townsend owns 92,453 shares of Apellis Pharmaceuticals Inc (APLS) as of February 12, 2024, with a value of $3 Million.
Latest Holdings of Adam J. Townsend
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-02-12 | 92,453 | 28.87 | 2,669,118 |
Holding Weightings of Adam J. Townsend
Adam J. Townsend Form 4 Trading Tracker
According to the SEC Form 4 filings, Adam J. Townsend has made a total of 19 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 1,148 shares on February 12, 2024, which brought Adam J. Townsend around $77,800.
Insider Trading History of Adam J. Townsend
- 1
Adam J. Townsend Trading Performance
Adam J. Townsend Ownership Network
Ownership Network List of Adam J. Townsend
Ownership Network Relation of Adam J. Townsend
Adam J. Townsend Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Adam J. Townsend is the See Remarks of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Adam J. Townsend made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,275,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,275,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Adam J. Townsend Mailing Address
Above is the net worth, insider trading, and ownership report for Adam J. Townsend. You might contact Adam J. Townsend via mailing address: C/o Apellis Pharmaceuticals, Inc., 6400 Westwind Way, Suite A, Crestwood Ky 40014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
